The forecasted mortality from chronic liver diseases and cirrhosis in Brazil indicates a gradual increase from 2024 to 2028. Starting at 20.43 thousand deaths in 2024 and rising to 21.09 thousand by 2028, this represents a steady upward trend. From 2024 to 2025, the year-on-year increase is approximately 0.83%, with similar increments through 2028. The Compound Annual Growth Rate (CAGR) from 2024 to 2028 is estimated to be consistent with these annual increments, depicting a stable rise in mortality rates.
Future trends to watch include potential impact from advancements in medical technology and healthcare policies, changes in socio-economic factors, and public health initiatives aimed at reducing the incidence and severity of liver diseases, which may alter this growth trajectory.
